This is the first I have heard them refer to Cell-in-a-Box(R) as a "biological product". I don't know if it has any significance but I have never heard this in a PR or seen it on their website before. I wonder if TD2 is considering it a "biological product" because of its many potential uses?
I am very anxious to hear that pre-clinical trials are starting. From what I understand of the PR, once we hear that, we should know relatively quickly if we will move into Phase 1 and then shortly after that, if we qualify for accelerated approval. It is all SO good, imo.
I did like the PR, it was professionally done, imo. Although I thought the intro a little over the top. After that, I felt the PR gave shareholders, like me, information needed to really understand what is going on behind the scenes right now.
I love the "quality of life" angle and it seems to be of prime importance to the FDA right now as well, according to the PR.
urup, I think with the factors of the FDA looking for "quality of life" drugs along with previous success rates and the fact that this is a rare disease, Cell-in-a-Box(R) may pass the MPI DRP with flying colors!
All my opinion, of course.
GLTA and have a great extended weekend! Let's remember all those who have died in service and have served our country! Here is to you and yours, Senior Chief and all those who have served us. Hope all is well.
NVLX ~ Cell-in-a-Box(R)
News 
Market Data 
Discover 
